NFKB1 and colitis: Xia’s research on Lacticplantibacillus plantarum for alleviating colitis found that this probiotic inhibits the expression of MyD88 and NF-kB/p65 signaling pathways and reduces pro-inflammatory factor TNF-α levels [32], which is consistent with the findings of this study.